Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Verve Therapeutics, Inc. VERV

Full chart Compare
Set alert

Price alert · VERV

All alert types
11.13 0.00 (+0.00%)

At closeJul 25, 2025, 4:00 PM EDT

11.13 Day range 11.13

52-week range unavailable

YTD
+97.34%
1 year
+57.20%

Financial health

Altman Z-Score

2.35 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.4×
FY 2019: -49.1×FY 2020: -34.0×FY 2021: -15.0×FY 2022: -6.6×FY 2023: -4.5×FY 2024: -2.4×
FY 2019 5y median -6.6× FY 2024
P/S 14.8×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 539×FY 2023: 76.1×FY 2024: 14.8×
FY 2019 5y median 14.8× FY 2024
P/B 1.0×
FY 2019: -47.6×FY 2020: -24.1×FY 2021: 5.0×FY 2022: 1.9×FY 2023: 1.5×FY 2024: 1.0×
FY 2019 5y median 1.5× FY 2024
P/FCF -3.0×
FY 2019: -100×FY 2020: -39.8×FY 2021: -21.7×FY 2022: -7.7×FY 2023: -5.6×FY 2024: -3.0×
FY 2019 5y median -7.7× FY 2024
EV/EBITDA -1.7×
FY 2019: -71.2×FY 2020: -42.1×FY 2021: -14.5×FY 2022: -6.2×FY 2023: -3.5×FY 2024: -1.7×
FY 2019 5y median -6.2× FY 2024
EV/Sales 11.6×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 521×FY 2023: 64.9×FY 2024: 11.6×
FY 2019 5y median 11.6× FY 2024
FCF Yield -33.8%
FY 2019: -1.0%FY 2020: -2.5%FY 2021: -4.6%FY 2022: -13.0%FY 2023: -17.8%FY 2024: -33.8%
FY 2019 5y median -13.0% FY 2024

Profitability

Gross Margin 100.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%
FY 2019 5y median 100.0% FY 2024
Operating Margin -707.2%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -8536.2%FY 2023: -1897.6%FY 2024: -707.2%
FY 2019 5y median -707.2% FY 2024
Net Margin -614.6%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -8108.6%FY 2023: -1701.5%FY 2024: -614.6%
FY 2019 5y median -614.6% FY 2024
ROE -40.3%
FY 2019: 97.3%FY 2020: 71.3%FY 2021: -33.2%FY 2022: -28.6%FY 2023: -33.4%FY 2024: -40.3%
FY 2019 5y median -33.2% FY 2024
ROIC -37.2%
FY 2019: -75.4%FY 2020: -57.1%FY 2021: -23.9%FY 2022: -25.3%FY 2023: -30.7%FY 2024: -37.2%
FY 2019 5y median -30.7% FY 2024
ROA -30.7%
FY 2019: -87.9%FY 2020: -58.1%FY 2021: -30.9%FY 2022: -23.2%FY 2023: -26.6%FY 2024: -30.7%
FY 2019 5y median -30.7% FY 2024

Growth (YoY)

Revenue 175.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 505.8%FY 2024: 175.0%
FY 2019 FY 2024
Operating Income -2.5%
FY 2019: 0.0%FY 2020: -197.8%FY 2021: -114.3%FY 2022: -90.3%FY 2023: -34.7%FY 2024: -2.5%
FY 2019 FY 2024
EPS (diluted) 24.7%
FY 2019: 0.0%FY 2020: -44.6%FY 2021: -160.6%FY 2022: -18.8%FY 2023: -7.2%FY 2024: 24.7%
FY 2019 FY 2024
Free Cash Flow -1.6%
FY 2019: 0.0%FY 2020: -316.1%FY 2021: -112.6%FY 2022: -64.8%FY 2023: -17.2%FY 2024: -1.6%
FY 2019 FY 2024

Financial Health

Current Ratio 12.6×
FY 2019: 5.4×FY 2020: 10.1×FY 2021: 16.7×FY 2022: 16.0×FY 2023: 17.2×FY 2024: 12.6×
FY 2019 5y median 16.0× FY 2024
Quick Ratio 12.6×
FY 2019: 5.4×FY 2020: 10.1×FY 2021: 16.7×FY 2022: 16.0×FY 2023: 17.2×FY 2024: 12.6×
FY 2019 5y median 16.0× FY 2024
Debt / Equity 0.1×
FY 2019: -1.8×FY 2020: -2.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×
FY 2019 5y median 0.1× FY 2024
Net Debt / EBITDA 0.5×
FY 2019: -2.4×FY 2020: -3.0×FY 2021: 0.5×FY 2022: 0.2×FY 2023: 0.6×FY 2024: 0.5×
FY 2019 5y median 0.5× FY 2024
Interest Coverage 0.0×
FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2019 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2019 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31